Lessons in Affect Regulation to Keep Stress and Pain UndeR Control (LARKSPUR R34)
LARKSPUR
Positive Affect Regulation as Adjuvant to Integrative Therapies for Chronic Pain: Development of the LARKSPUR Clinic-Based Intervention
1 other identifier
interventional
80
1 country
1
Brief Summary
Chronic pain affects millions of Americans but integrative as well as conventional treatments fall short in terms of alleviating this pain. The investigators are testing a tailored online positive affect skills intervention through a high-quality, randomized controlled trial for people with chronic musculoskeletal pain. The proposed work holds promise as an effective, low cost, easily disseminated intervention to help people cope with chronic pain, decrease depression and distress that pose barriers to optimal adherence, and potentially boost the efficacy of integrative as well as conventional pain treatments.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable chronic-pain
Started Oct 2018
Longer than P75 for not_applicable chronic-pain
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 19, 2018
CompletedFirst Posted
Study publicly available on registry
October 9, 2018
CompletedStudy Start
First participant enrolled
October 15, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2022
CompletedJanuary 26, 2023
January 1, 2023
4.2 years
July 19, 2018
January 24, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Retention to the LARKSPUR Study from baseline to 8 weeks post baseline
Retention will be defined as responding to the assessments at baseline and at 8 weeks post baseline
8 weeks; from baseline to 8 weeks post baseline
Retention to the LARKSPUR Study from baseline to 12 weeks post baseline
Retention will be defined as responding to the assessments at baseline and at 12 weeks post baseline
12 weeks; from baseline to 12 weeks post baseline
Secondary Outcomes (45)
Self-Reported Medication use at baseline
Administered at baseline
Self-Reported Medication use at 8 weeks post baseline
Administered at 8 weeks post baseline
Self-Reported Medication use at 12 weeks post baseline
Administered at 12 weeks post baseline
Modified Differential Emotions Scale (mDES)
Administered daily for 5 weeks of the intervention period
Daily Inventory of Stressful Events (DISE)
Administered daily for 5 weeks of the intervention period
- +40 more secondary outcomes
Other Outcomes (3)
Use of prescription medication in the patient's Electronic Health Record at 12 weeks post baseline
EHR data pull at 12 weeks post baseline
Use of non-prescription medication in the patient's Electronic Health Record at 12 weeks post baseline
EHR data pull at 12 weeks post baseline
Results of physical examinations in the patient's Electronic Health Record at 12 weeks post baseline
EHR data pull at 12 weeks post baseline
Study Arms (2)
Intervention
EXPERIMENTALParticipants will receive the online LARKSPUR intervention which lasts about 5-6 weeks, receiving the positive emotions skills through the website, and logging on to the website for about 5-10 minutes each day for that period. Assessments will be taken at baseline, post-intervention (8 weeks after the baseline), and 12 weeks after baseline (1 month post intervention).
Emotion Reporting Control
ACTIVE COMPARATORParticipants will report their emotions for 5-6 weeks by logging on to the website for about 5 minutes each day. Assessments will be taken at baseline, 8 weeks after baseline, and 12 weeks after baseline. After 12 weeks, participants will receive access to the LARKSPUR intervention online.
Interventions
8 positive emotion skills taught over 5-6 weeks to help individuals cope with chronic pain and stress.
Attention matched control condition, participants will report their daily emotions over 5-6 weeks online.
Eligibility Criteria
You may qualify if:
- Age 18 and over
- Current patient at Northwestern Memorial Hospital
- Seeking treatment for chronic musculoskeletal pain at the Northwestern Osher Center for Integrative Medicine. Pain will be defined as persisting for at least the past three months with an average level over the past month of at least 4 of 10 on a numerical rating scale, including back pain, neck pain/cervicalgia, knee pain, other joint pain (hips, ankles), fibromyalgia, osteoarthritis and rheumatoid arthritis.
- Fluent in the English language
- Have a working email address
- Have reliable Internet access in order to access the website online
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Northwestern Universitylead
- BraveNetcollaborator
Study Sites (1)
Osher Center for Integrative Medicine
Chicago, Illinois, 60611, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
July 19, 2018
First Posted
October 9, 2018
Study Start
October 15, 2018
Primary Completion
December 31, 2022
Study Completion
December 31, 2022
Last Updated
January 26, 2023
Record last verified: 2023-01